Literature DB >> 3207640

A prospective study of colposcopy in women with mild dyskaryosis or koilocytosis.

B S Bolger1, B V Lewis.   

Abstract

Colposcopy was performed in 91 women who had cervical cytology suggesting mild dyskaryosis or showing koilocytosis, all previous cytology having been normal. The final histological diagnosis was CIN III in 22%, CIN II in 18%, CIN I in 31%, koilocytosis alone in 14% and no abnormality in 15%. These results indicate that even with mild cytological atypia, a high proportion of patients will have more advanced disease when colposcopy-directed punch biopsy is performed.

Entities:  

Mesh:

Year:  1988        PMID: 3207640     DOI: 10.1111/j.1471-0528.1988.tb06788.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  5 in total

1.  Management of women with mild dyskaryosis. Immediate referral to colposcopy is safer.

Authors:  W P Soutter
Journal:  BMJ       Date:  1994-09-03

Review 2.  Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.

Authors:  Maria Kyrgiou; Ilkka E J Kalliala; Anita Mitra; Christina Fotopoulou; Sadaf Ghaem-Maghami; Pierre Pl Martin-Hirsch; Margaret Cruickshank; Marc Arbyn; Evangelos Paraskevaidis
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

3.  Cost-effectiveness of active versus conservative colposcopic management of mild dyskaryosis.

Authors:  Mohsen M El-Sayed; Wael I Al-Daraji; Chris M Finnegan; Wendy E Dugmore; Barbel U Vonau; Paul G Carter; Michael H Jones
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

4.  Diagnosis and treatment of cervical intraepithelial neoplasia in general practice.

Authors:  D B Johnson; C J Rowlands
Journal:  BMJ       Date:  1989-10-28

5.  Study of viral integration of HPV-16 in young patients with LSIL.

Authors:  G Gallo; M Bibbo; L Bagella; A Zamparelli; F Sanseverino; M R Giovagnoli; A Vecchione; A Giordano
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.